If you're still searching for relief from kidney disease progression, especially if other treatments haven't fully helped, consider a potential new treatment option for CKD.
This Phase II study is evaluating MZE829, an investigational treatment, as a potential therapy to slow kidney disease progression in patients with APOL1-mediated kidney disease and proteinuria.
The study includes a 2-week run-in period followed by 52 weeks of treatment and a 1-week follow-up. Regular clinic visits will monitor your progress throughout the study.
The study is being conducted at Access Research Institute, located at 11373 Cortez Blvd Building C, Suite 200, Brooksville, FL 34613.
Understanding the science behind this investigational therapy being studied for CKD
This investigational medication represents a new approach to potentially treating APOL1-associated kidney disease. By targeting pathways involved in kidney cell protection, this therapy is being studied for its potential to slow the progression of chronic kidney disease.
Research has shown that APOL1 gene variations are associated with increased risk of kidney disease in people of African ancestry. In people with these variations, certain pathways may contribute to ongoing kidney damage. By potentially targeting these pathways, this investigational treatment is being evaluated for its ability to help protect kidney function.
MZE829 is designed to target pathways involved in APOL1-mediated kidney disease.
Focuses on protecting kidney function in people with certain genetic variations.
It works by potentially protecting kidney cells from damage and inflammation.
Aims to slow the progression of chronic kidney disease.
By protecting kidney cells, the investigational medication may help preserve kidney function over time.
Currently under investigation in clinical trials.
This represents a new approach to treating APOL1-associated kidney disease.
Being studied for its safety and efficacy in this specific population.
Dr. Salman currently serves as program director for the Internal Medicine Residency Program at Oak Hill Hospital. He received his medical degree from Quaid-e-Azam University and his pre-medical training was at Sir Syed College. He then served for 13 years at Seton Hall University Internal Medicine Program at Saint Francis Medical Center in New Jersey where he completed his internal medicine residency and was a chief resident.
Internal Medicine
Consumer Research Council of America 2010, 2011, 2014 & 2015
Clinical Experience
"As a doctor, I see how challenging kidney disease can be. This study is a way for us to explore potential options that may help people feel better and live healthier lives. Every person who joins helps us move one step closer to better care in the future."
Participating in this study offers several potential advantages for patients with APOL1-associated kidney disease.
Ready to join our clinical study? It's simple. Just follow these easy steps.
Schedule your first chat with our friendly team. We'll talk about your health and see if this study is a good fit for you. We'll go over your health background, current care, and understand your condition better.
Next, we'll do a quick check-up to make sure the study is right for your specific needs. We'll walk you through everything about the study – the potential benefits and risks, what to expect, and answer all your questions.
If you feel ready to move forward, you'll review and sign the informed consent form. This important paper explains everything: what happens in the study, the timeline, and your rights as a participant.
Embark on your study journey and begin your first treatment session! You'll get a personalized treatment plan made just for you, along with a clear schedule for your participation.
Find answers to common questions about our clinical research study.
Have more questions about the study?
Call Our Friendly TeamFind out if you're a good fit for this investigational study. Our team will contact you within 24 hours.
Voluntary Participation
We can only accept a limited number of participants for this investigational study.
No-Cost Evaluation
Your consultation and all study-related care is provided at no cost to qualified participants.
No Obligation
The consultation is informational only - you decide if this investigational study is right for you.
Visit our clinic location in Brooksville, FL for your consultation and study visits.
11373 Cortez Blvd Building C, Suite 200
Brooksville, FL 34613
Monday-Friday
9am-5pm
Free parking
Wheelchair accessible